Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data

By Julie Steenhuysen CHICAGO (Reuters) - Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most ...

Related Keywords

New York ,United States ,Chicago ,Illinois ,American ,Merck Moderna ,Julie Steenhuysen ,Andrew Allen ,Merck Keytruda ,Jane Healy ,Vinod Balachandran ,Roche Tecentriq ,Caroline Humer ,Gritstone Bio Inc ,Merck Co ,Researchers At Memorial Sloan Kettering Cancer Center ,Moderna Inc ,Reuters ,American Society Of Clinical Oncology ,American Society ,Clinical Oncology ,Memorial Sloan Kettering Cancer Center ,Bill Berkrot ,